Metabolomics in the Developing Human Being

Pediatric Clinics of North America

Volumn 59, Issue 5, 2012, Pages 1039-1058

  Syggelou, Aggeliki ^a   Iacovidou, Nicoletta ^a   Atzori, Luigi ^b   Xanthos, Theodoros ^a   Fanos, Vassilios ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Childhood; Metabolomics; Neonate; Prenatal health

Indexed keywords

BIOLOGICAL MARKER;

BIOCHEMICAL COMPOSITION; BLOOD SAMPLING; DISEASE MODEL; FETUS MALFORMATION; GENOTYPE; HUMAN; HUMAN DEVELOPMENT; INSULIN DEPENDENT DIABETES MELLITUS; MATERNAL WELFARE; METABOLITE; METABOLOMICS; METHYLMALONIC ACIDEMIA; NONHUMAN; PATHOGENESIS; PNEUMONIA; PREECLAMPSIA; PRENATAL PERIOD; PROPIONIC ACIDEMIA; REVIEW; URINALYSIS;

ANIMALS; BIOMEDICAL RESEARCH; CHILD; HUMAN DEVELOPMENT; HUMANS; INFANT; METABOLOMICS; YOUNG ADULT;

EID: 84867033364     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2012.07.002     Document Type: Review

References (89)

1. Atzori L., Noto A., Barberini L., et al. Metabolomics in perinatal renal asphyxia. Developmental nephrology: from embryology to metabolomics 2011, 181-193. Hygeia Press, Quartu S. Elena (Italy). 1st edition. V. Fanos, R.L. Chevalier, G. Faa (Eds.).
2. Biomarkers of kidney disease 2011, Elsevier Inc, London (England). 1st edition. C.L. Edelstein (Ed.).
3. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455:1054-1056.
4. Metabolome analysis: an introduction 2007, Wiley Blackwell, Hoboken (NJ). S.G. Villas-Boas, J. Nielsen, J. Smedsgaard (Eds.).
5. Lindon J.C., Nicholson J.K. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem (Palo Alto Calif) 2008, 1:45-69.
6. Want E.J., Wilson I.D., Gika H., et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 2010, 5:1005-1018.
7. Oliver S.G., Winson M.K., Kell D.B., et al. Systematic functional analysis of the yeast genome. Trends Biotechnol 1998, 16:373-378.
8. Biomarkers Definition Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
9. Nicholson J.K. Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2006, 2:52.
10. Holmes E., Wilson I.D., Nicholson J.K. Metabolic phenotyping in health and disease. Cell 2008, 134:714-717.
11. Sieber M, editor. Evaluation of 1H NMR- and GC/MS-based metabonomics for the assessment of liver and kidney toxicity. Evaluation of 1H NMR- and GC/MS-based metabonomics for the assessment of liver and kidney toxicity. Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Julius-Maximilians-Universität Würzburg. 2009.
12. Fanos V., Antonucci R., Barberini L., et al. Clinical application of metabolomics in neonatology. J Matern Fetal Neonatal Med 2012, 25(Suppl 1):104-109.
13. Coen M., Holmes E., Lindon J.C., et al. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2008, 21:9-27.
14. Atzori L., Antonucci R., Barberini L., et al. Metabolomics: a new tool for the neonatologist. J Matern Fetal Neonatal Med 2009, 22(Suppl 3):50-53.
15. Fell J.M., Thakkar H., Newman D.J., et al. Measurement of albumin and low molecular weight proteins in the urine of newborn infants using a cotton wool ball collection method. Acta Paediatr 1997, 86:518-522.
16. Cuzzolin L., Mangiarotti P., Fanos V. Urinary PGE(2) concentrations measured by a new EIA method in infants with urinary tract infections or renal malformations. Prostaglandins Leukot Essent Fatty Acids 2001, 64:317-322.
17. Agostiniani R., Mariotti P., Cataldi L., et al. Role of renal PGE2 in the adaptation from foetal to extrauterine life in term and preterm infants. Prostaglandins Leukot Essent Fatty Acids 2002, 67:373-377.
18. Wilson I.D. Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring. Proc Natl Acad Sci U S A 2009, 106:14187-14188.
19. Antonucci R., Atzori L., Barberini L., et al. Metabolomics: the " new clinical chemistry" for personalized neonatal medicine. Minerva Pediatr 2010, 62(3 Suppl 1):145-148.
20. Fanos V., Yurdakök M. Personalized neonatal medicine. J Matern Fetal Neonatal Med 2010, 23(Suppl 3):4-6.
21. Baraldi E., Carraro S., Giordano G., et al. Metabolomics: moving towards personalized medicine. Ital J Pediatr 2009, 35:30.
22. Kroemer H.K., Meyer zu Schwabedissen H.E. A piece in the puzzle of personalized medicine. Clin Pharmacol Ther 2010, 87:19-20.
23. Fanos V. Cells, the tree, medicines and the tailor. Editorial. Curr Pharm Des 2012, 18(21):2995.
24. Weiss R.H., Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol 2011, 8:22-33.
25. Dunn W.B., Broadhurst D.I., Atherton H.J., et al. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011, 40:387-426.
26. Wu H., Southam A.D., Hines A., et al. High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Anal Biochem 2008, 372:204-212.
27. Patti G.J., Yanes O., Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012, 13:263-269.
28. Kell D.B., Brown M., Davey H.M., et al. Metabolic footprinting and systems biology: the medium is the message. Nat Rev Microbiol 2005, 3:557-565.
29. Resampling-based multiple testing: examples and methods for P-value adjustment 1993, John Wiley & Sons, New York. P.H. Westfall, S.S. Young (Eds.).
30. Benjamini Y., Drai D., Elmer G., et al. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284.
31. Perpiñá Tordera M. Complexity in asthma: inflammation and scale free networks. Arch Bronconeumol 2009, 45:459-465.
32. Mori M. Study of protein biosynthesis in fetus and placenta. I. Incorporation of C-14-amino acids into the human placenta. Am J Obstet Gynecol 1965, 93:1164-1171.
33. Diaz S.O., Pinto J., Graça G., et al. Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. J Proteome Res 2011, 10:3732-3742.
34. Graca G., Duarte I.F., Barros A.S., et al. Impact of prenatal disorders on the metabolic profile of second trimester amniotic fluid: a nuclear magnetic resonance metabonomic study. J Proteome Res 2010, 9:6016-6024.
35. Horgan R.P., Clancy O.H., Myers J.E., et al. An overview of proteomic and metabolomic technologies and their application to pregnancy research. BJOG 2009, 116:173-181.
36. Kenny L.C., Broadhurst D.I., Dunn W., Screening for pregnancy endpoints consortium, et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 2010, 56:741-749.
37. Odibo A.O., Goetzinger K.R., Odibo L., et al. First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn 2011, 31:990-994.
38. Heazell A.E., Brown M., Worton S.A., et al. Review: the effects of oxygen on normal and pre-eclamptic placental tissue-insights from metabolomics. Placenta 2011, 32(Suppl 2):S119-S124.
39. Horgan R.P., Broadhurst D.I., Dunn W.B., et al. Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies. Placenta 2010, 31:893-901.
40. Romero R., Mazaki-Tovi S., Vaisbuch E., et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med 2010, 23:1344-1359.
41. Beecher C.W. Metabolomic studies at the start and end of the life cycle. Clin Biochem 2011, 44:518-519.
42. Keller M., Enot D.P., Hodson M.P., et al. Inflammatory-induced hibernation in the fetus: priming of fetal sheep metabolism correlates with developmental brain injury. PLoS One 2011, 6:e29503.
43. Solberg R., Enot D., Deigner H.P., et al. Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs. PLoS One 2010, 5:e9606.
44. Atzori L., Xanthos T., Barberini L., et al. A metabolomic approach in an experimental model of hypoxia-reoxygenation in newborn piglets: urine predicts outcome. J Matern Fetal Neonatal Med 2010, 23(Suppl 3):134-137.
45. Beckstrom A.C., Humston E.M., Snyder L.R., et al. Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model. J Chromatogr A 2011, 1218:1899-1906.
46. Gore D.C., Jahoor F., Hibbert J., et al. Except for alanine, muscle protein catabolism is not influenced by alterations in glucose metabolism during sepsis. Arch Surg 1995, 130:1171-1176.
47. Bolton C.F. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996, 24:1408-1416.
48. Vulimiri S.V., Misra M., Hamm J.T., et al. Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells. Chem Res Toxicol 2009, 22:492-503.
49. Singer M., De Santis V., Vitale D., et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364:545-548.
50. McClay J.L., Adkins D.E., Isern N.G., et al. (1)H nuclear magnetic resonance metabolomics analysis identifies novel urinary biomarkers for lung function. J Proteome Res 2010, 9:3083-3090.
51. Sotoda Y., Negoro M., Wakabayashi I. Involvement of decreased myo-inositol transport in lipopolysaccharide-induced depression of phosphoinositide hydrolysis in vascular smooth muscle. FEBS Lett 2002, 519:227-230.
52. Izquierdo-García J.L., Nin N., Ruíz-Cabello J., et al. A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med 2011, 37(2):2023-2032.
53. Beckstrom A.C., Tanya P., Humston E.M., et al. The perinatal transition of the circulating metabolome in a nonhuman primate. Pediatr Res 2012, 71:338-344.
54. Liu J., Litt L., Segal M.R., et al. Outcome-related metabolomic patterns from 1H/31P NMR after mild hypothermia treatments of oxygen-glucose deprivation in a neonatal brain slice model of asphyxia. J Cereb Blood Flow Metab 2011, 31:547-559.
55. Hanna M, Segar S, Teesch L, et al. Metabolomics markers of nephrotoxicity in newborn rats. Poster presented at PAS/ASPR 2011. Denver (CO), April 30-May 3, 2011.
56. Jiang P, Berri T, Ladegaard Jensen M, et al. Urine metabolome of preterm neonates with treatment of antibiotics. Presented at the Metabomeeting 2011. Helsinki, September 25-28, 2011. Poster 54.
57. Dessì A., Atzori L., Noto A., et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011, 24(Suppl 2):35-39.
58. Hyde M.J., Griffin J.L., Herrera E., et al. Delivery by caesarean section, rather than vaginal delivery, promotes hepatic steatosis in piglets. Clin Sci (Lond) 2009, 118:47-59.
59. Ciccarelli S., Atzori L., Noto A., et al. Spontaneous vs cesarean delivery: a metabolomic point of view. J Matern Fetal Neonatal Med 2011, 24:I-II. [abstract].
60. Atzori L., Antonucci R., Barberini L., et al. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) 2011, 3:1005-1012.
61. Fabiano A., Gazzolo D., Zimmermann L.J., et al. Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results. J Matern Fetal Neonatal Med 2011, 24(Suppl 2):55-58.
62. Atzori L., Barberini L., Lussu M., et al. Metabolomics and patent ductus arteriosus diagnosis: is 1H-NMR (nuclear magnetic resonance) spectroscopy of urine at birth predictive as ultrasound?. J Matern Fetal Neonatal Med 2011, 24(Suppl):I. [abstract].
63. Marincola F.C., Reali A., Barberini L., et al. NMR metabolic target analysis of the aqueous human breast extract. J Matern Fetal Neonatal Med 2011, 24:V. [abstract].
64. Marincola F.C., Noto A., Reali A., et al. Metabolomic study (aqueous and lipidic extract) of breast milk and formula milk for preterm babies. Proceedings XX European Workshop on Neonatology, Tallin June 1012 [abstract 11]. J Neonatal Perinatal Med 2012, 5(2):194-195.
65. Noto A, Paladini L, Paladini A, et al. Metabolomics in twins at birth. Proceedings XX European Workshop on Neonatology, Tallin June 1012 [abstract 12]. J Neonatal Perinatal Med, in press.
66. Atzei A., Atzori L., Moretti C., et al. Metabolomics in paediatric respiratory diseases and bronchiolitis. J Matern Fetal Neonatal Med 2011, 24(Suppl 2):59-62.
67. Banupriya C., Ratnakar P., Doureradjou N., et al. Can urinary excretion rate of malondialdehyde, uric acid and protein predict the severity and impending death in perinatal asphyxia?. Clin Biochem 2008, 41:968-973.
68. Ricquier D. Med Sci (Paris) 2005, 21:512-516. [in French].
69. Wikoff W.R., Gangoiti J.A., Barshop B.A., et al. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 2007, 53:2169-2176.
70. Gu H., Pan Z., Xi B., et al. 1H NMR metabolomics study of age profiling in children. NMR Biomed 2009, 22:826-833.
71. Fanos V., Barberini L., Antonucci R., et al. Metabolomics in neonatology and pediatrics. Clin Biochem 2011, 44:452-454.
72. Slupsky C.M. NMR-based analysis of metabolites in urine provides rapid diagnosis and etiology of pneumonia. Biomark Med 2010, 4:195-197.
73. Laiakis E.C., Morris G.A., Fornace A.J., et al. Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One 2010, 5(9):e12655.
74. Oresic M., Simell S., Sysi-Aho M., et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 2008, 205:2975-2984.
75. Zuppi C., Messana I., Tapanainen P., et al. Proton nuclear magnetic resonance spectral profiles of urine from children and adolescents with type 1 diabetes. Clin Chem 2002, 48:660-662.
76. Costacou T., Ferrel R.E., Ellis D., et al. Haptoglobin genotype and renal function decline in type 1 diabetes. Diabetes 2009, 58:2904-2909.
77. Carraro S., Rezzi S., Reniero F., et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007, 175:986-990.
78. Saude E.J., Skappak C.D., Regush S., et al. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol 2011, 127:757-764.
79. Mattarucchi E., Baraldi E., Guillou C. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomed Chromatogr 2012, 26:89-94.
80. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
81. Dent C.L., Ma Q., Dastrala S., et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007, 11:R127.
82. Bennett M., Dent C.L., Ma Q., et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008, 3:665-673.
83. Al-Ismaili Z., Palijan A., Zappitelli M. Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application. Pediatr Nephrol 2011, 26:29-40.
84. Washburn K.K., Zappitelli M., Arikan A.A., et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant 2008, 23:566-572.
85. Atzori L., Antonucci R., Barberini L., et al. 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front Biosci (Elite Ed) 2010, 2:725-732.
86. Robroeks C.M., van Berkel J.J., Dallinga J.W., et al. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res 2010, 68:75-80.
87. Kawashima H., Oguchi M., Ioi H., et al. Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics. Int J Neurosci 2006, 116:927-936.
88. Atzori L., Mussap M., Noto A., et al. Clinical metabolomics and urinary NGAL for the early prediction of chronic kidney disease in healthy adults born ELBW. J Matern Fetal Neonatal Med 2011, 24:40-43.
89. Modi N., Hyde M.J., Parkinson J., et al. European workshop on neonatology September 2010. J Neonatal Perinatal Med 2010, 3(3):254. [abstract].